Article info
Concise report
Evidence for negative association of the chemokine receptor CCR5 d32 polymorphism with rheumatoid arthritis
- Correspondence to:
Dr Lachy McLean
Clinical Immunology and Analgesia, Merck and Co, RY34B-278, PO Box 2000, Rahway, NJ 07065, USA; iain_mcleanmerck.com
Citation
Evidence for negative association of the chemokine receptor CCR5 d32 polymorphism with rheumatoid arthritis
Publication history
- Accepted July 6, 2004
- First published August 26, 2004.
Online issue publication
February 11, 2005
Article Versions
- Previous version (26 August 2004).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright 2005 by Annals of the Rheumatic Diseases